Catheter Precision (VTAK) announced the launch of its LockeT suture retention device in Switzerland. The first clinical cases were performed at Spitalzentrum Biel, led by PD Dr. Rainer Zbinden, with excellent procedural outcomes and positive feedback from both the clinical and nursing teams. This milestone follows the company’s recent strategic distribution agreement with FuMedica AG, a premier Swiss medical device distributor with a strong presence in cardiovascular and interventional medicine. The partnership enables the introduction of LockeT to hospitals and clinics across Switzerland, further expanding Catheter Precision’s European footprint.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision announces addition of key ablation procedures to ASC by CMS
- Catheter Precision Ends At-Market-Offering Agreement
- Catheter Precision announces successful LockeT launch in South Africa
- Catheter Precision announces third VIVO installation in France
- Catheter Precision enters distribution agreement with FuMedica